The integration of the sequence of each single cell coupled with IsoPlexis’ proprietary functional proteomics accelerates insights into discovery biology & development of advanced medicines BRANFORD, Conn. — IsoPlexis, the leader in functional single-cell proteomics, today announced the acquisition of an extensive intellectual property portfolio of 86 patents related to DNA and RNA sequencing. These nucleic […]
Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, today announced the successful completion of Series A4 financing. Sequoia Capital China led this round of investment, and was joined by Green Pine Capital Partners and Primavera Venture Partners. IDG Capital, the original founding investor for Analytical Biosciences, also participated in this financing round. Analytical […]
m2p-labs, BioLector family of products acquired by Beckman Coulter Life Sciences in 2020 BAESWEILER, GERMANY – Microbioreactor technology is accelerating and increasing automation capabilities with the launch of the new BioLector XT Microbioreactor which features the highest flexibility, enabling more applications in the BioLector series of instruments from m2p-labs, part of the Beckman Coulter Life […]
A New Platform to Simplify Deep Profiling of the Human Immune SystemSOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the launch of CyTOF® XT, designed to simplify the design and execution of deep cell profiling studies, standardize sample analysis […]
Cellenion and ECOBIO laboratory (UMR CNRS-University of Rennes) have received a Labcom-2020 €360k grant by the French National Research Agency (ANR) for the creation of the joint MICROSCALE-Lab (MICRObial Single Cell AnaLysEs Laboratory). The overall objective of this 5-year project is to offer a complete solution for the isolation, library preparation and bioinformatic analysis of […]
CELLINK has acquired Visikol Corp., an American contract research services company offering leading services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharma and biotech companies. CELLINK has acquired all outstanding shares in Visikol for a purchase price of $7.5 million on a cash- and debt-free basis under the assumption that […]
FREDERICK, Md. — RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems for cell and gene therapy product developers, today announced the launch of its product RoosterGEM™, a stand-alone, complete gene transfer medium that is optimized to remove key challenges in primary cell genetic modification. RoosterGEM, abbreviated for Rooster […]
CELLINK AB (publ) (“CELLINK”) has entered into an agreement with the shareholders of Nanoscribe Holding GmbH (“Nanoscribe”), a market leading and award-winning German company focusing on development of high-precision 3D printers based on Two-Photon Polymerization technology (“2PP”), to acquire all outstanding shares on a cash- and debt-free basis, and under the assumption that the working […]
InSphero and Hamilton Announce Collaboration to Improve the Production and Handling of Spheroids Using Advanced Liquid Handling Technology Both partners have a proven track record for being a successful entrepreneur and a technical disruptor at the intersection of 3D in vitro technologies and automation. Schlieren, Switzerland – InSphero AG, the pioneer of 3D cell-based assay technology […]
Using High-Plex Spatial Proteomics to Examine Immune Response ST. LOUIS, Missouri — Canopy Biosciences, a Bruker Company, today announced the successful development of a new assay for examining immune response to COVID-19. The assay uses high-plex spatial proteomics and is performed on Canopy’s ZellScannerONE precise spatial phenotyping instrument. ZellScannerONE enables multiplexed spatial quantification of protein biomarkers in tissue […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
